Identifying novel therapeutic targets in high-risk MYCN-amplified neuroblastoma: a QBI/SBI Online Seminar with Melinda Halasz Read more about Identifying novel therapeutic targets in high-risk MYCN-amplified neuroblastoma: a QBI/SBI Online Seminar with Melinda Halasz Wed, 09/07/2022 - 10:00 - Wed, 09/07/2022 - 11:00
Integrative mechanisms underlying the evolution of drug resistance in oncogene-driven lung cancer: a QBI Online Seminar with Trever Bivona Read more about Integrative mechanisms underlying the evolution of drug resistance in oncogene-driven lung cancer: a QBI Online Seminar with Trever Bivona Wed, 03/02/2022 - 09:00 - Wed, 03/02/2022 - 10:00